Decreased fibrosis during corticosteroid therapy of autoimmune hepatitis
Open Access
- 30 April 2004
- journal article
- Published by Elsevier BV in Journal of Hepatology
- Vol. 40 (4), 646-652
- https://doi.org/10.1016/j.jhep.2004.01.009
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Sustained remission after corticosteroid therapy for type 1 autoimmune hepatitis: A retrospective analysisHepatology, 2002
- Decreasing fibrogenesis: an immunohistochemical study of paired liver biopsies following lamivudine therapy for chronic hepatitis BJournal of Hepatology, 2001
- International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitisJournal of Hepatology, 1999
- Transforming growth factor‐β: crossroad of glucocorticoid and bleomycin regulation of collagen synthesis in lung fibroblastsWound Repair and Regeneration, 1999
- Frequency and significance of antibodies to actin in type 1 autoimmune hepatitisHepatology, 1996
- Histological grading and staging of chronic hepatitisJournal of Hepatology, 1995
- Survival and histological resolution of fibrosis in patients with autoimmune chronic active hepatitisJournal of Hepatology, 1993
- The Cellular Basis of Hepatic Fibrosis -- Mechanisms and Treatment StrategiesNew England Journal of Medicine, 1993
- Transforming Growth Factors β1 and α in Chronic Liver DiseaseNew England Journal of Medicine, 1991
- Complete Resolution of Inflammatory Activity Following Corticosteroid Treatment of HBsAg-Negative Chronic Active HepatitisHepatology, 1984